Letter to the Editor: "Transdermal vs Oral Estrogen Therapy and Venous Thromboembolism: Upgrade the Level of Evidence" by

Pierre-Yves Scarabin; Marianne Canonico; Valérie Scarabin-Carré; Emmanuel Oger

doi:10.1210/jc.2015-4248

Journal articles

Letter to the Editor: "Transdermal vs Oral Estrogen Therapy and Venous Thromboembolism: Upgrade the Level of Evidence" by

Pierre-Yves Scarabin ¹ Marianne Canonico ¹ Valérie Scarabin-Carré ¹ Emmanuel Oger ^{2, 3}

1 CESP - Centre de recherche en épidémiologie et santé des populations

2 Service d'anatomie et cytologie pathologiques [Rennes] = Anatomy and Cytopathology [Rennes]

3 CIC - Centre d'Investigation Clinique [Rennes]

Abstract : Scarabin PY, et meta-analysis by Mohammed et al (1) confirms the safety advantage of transdermal vs oral estrogens with respect to the risk of venous thromboembolism (VTE). Surprisingly, the quality of evidence is described as very low (see Table 4 in the report). We believe that this quality rating based on “the observational nature of the studies and inconsistency of results” is not appropriate...

Document type :

Journal articles

Domain :

Life Sciences [q-bio]

Complete list of metadata

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01274220
Contributor : Laurent Jonchère Connect in order to contact the contributor
Submitted on : Monday, February 15, 2016 - 4:03:56 PM
Last modification on : Tuesday, November 23, 2021 - 2:18:05 PM

Letter to the Editor: "Transdermal vs Oral Estrogen Therapy and Venous Thromboembolism: Upgrade the Level of Evidence" by

Links full text

Identifiers

Collections

Citation

Export

Metrics

696

Letter to the Editor: "Transdermal vs Oral Estrogen Therapy and Venous Thromboembolism: Upgrade the Level of Evidence" by

Links full text

Identifiers

Collections

Citation

Export

Share

Metrics

696